Nephro Care India Statistics

Total Valuation

NSE:NEPHROCARE has a market cap or net worth of INR 1.43 billion. The enterprise value is 1.29 billion.

Market Cap	1.43B
Enterprise Value	1.29B

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:NEPHROCARE has 16.49 million shares outstanding. The number of shares has increased by 24.16% in one year.

Current Share Class	16.49M
Shares Outstanding	16.49M
Shares Change (YoY)	+24.16%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	65.44%
Owned by Institutions (%)	5.95%
Float	5.70M

Valuation Ratios

The trailing PE ratio is 53.68.

PE Ratio	53.68
Forward PE	n/a
PS Ratio	1.88
PB Ratio	2.58
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	41.66
EV / Sales	1.69
EV / EBITDA	17.15
EV / EBIT	38.57
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	28.57

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.87%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.28M
Profits Per Employee	92,558
Employee Count	334
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:NEPHROCARE has paid 11.61 million in taxes.

Income Tax	11.61M
Effective Tax Rate	27.30%

Stock Price Statistics

The stock price has decreased by -39.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.51%
50-Day Moving Average	74.47
200-Day Moving Average	117.82
Relative Strength Index (RSI)	64.61
Average Volume (20 Days)	22,860

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NEPHROCARE had revenue of INR 761.59 million and earned 30.91 million in profits. Earnings per share was 1.61.

Revenue	761.59M
Gross Profit	406.88M
Operating Income	33.40M
Pretax Income	42.53M
Net Income	30.91M
EBITDA	75.11M
EBIT	33.40M
Earnings Per Share (EPS)	1.61

Full Income Statement

Balance Sheet

The company has 140.51 million in cash and n/a in debt, giving a net cash position of 140.51 million or 8.52 per share.

Cash & Cash Equivalents	140.51M
Total Debt	n/a
Net Cash	140.51M
Net Cash Per Share	8.52
Equity (Book Value)	554.28M
Book Value Per Share	33.65
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	41.71M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.42%, with operating and profit margins of 4.39% and 4.06%.

Gross Margin	53.42%
Operating Margin	4.39%
Pretax Margin	5.58%
Profit Margin	4.06%
EBITDA Margin	9.86%
EBIT Margin	4.39%
FCF Margin	n/a

Dividends & Yields

NSE:NEPHROCARE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.16%
Shareholder Yield	-24.16%
Earnings Yield	2.16%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1